NCT03694379

Brief Summary

This RCT is testing the efficacy of apneic oxygenation during endotracheal intubation in the emergency department. Currently the standard practice in the ED when performing endotracheal intubation is that some providers use apneic oxygenation (the application of a nasal cannula at 15LPM) throughout the intubation procedure, while others do not apply apneic oxygenation. Initial literature in the operating room showed that apneic oxygenation helps prevent desaturation during the procedure. However, the latest literature conducted in critical care settings (one study in the ICU and one in the ED) questions the efficacy of this intervention in critically ill patients; however, no harm has been shown. Our study aims to test this intervention further by adding in a special subset of patients that was excluded from prior studies, precipitous intubations, or those patients that have to be intubated quickly and cannot have adequate pre-oxygenation. We hypothesize that apneic oxygenation will be more efficacious in this subset than in the overall ED population. We will randomize patients requiring endotracheal intubation into intervention (apneic oxygenation) and control (no apneic oxygenation). We will measure the lowest arterial oxygen saturation from the start of the intubation procedure through 2 minutes after intubation is complete.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2018

Completed
22 days until next milestone

First Posted

Study publicly available on registry

October 3, 2018

Completed
5 months until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 22, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 22, 2020

Completed
Last Updated

March 25, 2020

Status Verified

March 1, 2020

Enrollment Period

1.1 years

First QC Date

September 11, 2018

Last Update Submit

March 22, 2020

Conditions

Keywords

Apneic OxygenationEndotracheal intubationAirway ManagementEmergency Department

Outcome Measures

Primary Outcomes (1)

  • Lowest oxygen saturation overall

    Lowest oxygen saturation between overall control and intervention groups

    Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation

Secondary Outcomes (14)

  • Lowest oxygen saturation precipitous intubations

    Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation

  • Lowest oxygen saturation pre-oxygenation

    Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation

  • Difference in baseline and final oxygen saturation

    Decision to intubate through 2 minutes after completion of endotracheal intubation

  • Difference in oxygen saturation before and after apneic period

    Initiation of neuromuscular blockade through 2 minutes after completion of endotracheal intubation

  • Desaturation

    Initiation of neuromuscular blockade through 2 minutes after completion of endotracheal intubation

  • +9 more secondary outcomes

Study Arms (2)

Apneic Oxygenation

EXPERIMENTAL

Participants receiving apneic oxygenation

Other: Apneic oxygenation during endotracheal intubation

No Apneic Oxygenation

NO INTERVENTION

Participants not receiving apneic oxygenation

Interventions

Providing oxygenation through nasal cannula during the apneic phase of endotracheal intubation.

Apneic Oxygenation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital

Newark, New Jersey, 07103, United States

Location

MeSH Terms

Conditions

Emergencies

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ilya Ostrovsky, MD

    Rutgers, The State University of New Jersey

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Emergency Medicine

Study Record Dates

First Submitted

September 11, 2018

First Posted

October 3, 2018

Study Start

March 1, 2019

Primary Completion

March 22, 2020

Study Completion

March 22, 2020

Last Updated

March 25, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations